Bauman Tyler M, Potretzke Aaron M, Wright Alec J, Knight Brent A, Vetter Joel M, Figenshau Robert Sherburne
1 Department of Surgery, Division of Urologic Surgery, Washington University School of Medicine , St. Louis, Missouri.
2 Department of Urology, Mayo Clinic , Rochester, Minnesota.
J Endourol. 2017 Apr;31(4):412-417. doi: 10.1089/end.2016.0667. Epub 2017 Feb 3.
The aim of this study was to investigate the incidence of benign histology after partial nephrectomy (PN) in patients with presumed malignancy from preoperative imaging. Furthermore, preoperative predictors of benign lesions and perioperative outcomes were also assessed.
A series of patients undergoing PN for renal masses was identified using a prospectively maintained database. Patients were excluded for known genetic conditions, if more than one renal mass was resected, or if standard preoperative imaging was not suspicious for renal-cell carcinoma (RCC). Differences in characteristics between patients with benign and malignant pathology were assessed.
A total of 916 patients were identified who underwent PN between 2007 and 2015, including 129 (14.1%) patients with a final diagnosis of benign disease. The most common types of benign pathology were oncocytoma (n = 66, 51.2%), angiomyolipoma (n = 37, 28.7%), and complex cysts (n = 10, 7.8%). Low body mass index (BMI) [0.96 (0.92-0.99) p = 0.02], low R.E.N.A.L. score [0.86 (0.76-0.96) p = 0.007], and low preoperative creatinine [0.37 (0.14-0.91) p = 0.04] predicted benign histology in multivariate analysis. Tumor size was a significant predictor in additional modeling [0.81 (0.69-0.94) p = 0.008]. Patients with benign histology had significantly shorter operative times (p < 0.001) and less estimated blood loss (p < 0.001), and there was no difference in complication (p = 0.93) or blood transfusion (0.24) rates.
In this study, the rate of benign pathology after PN for presumed RCC is 14.1%. BMI, R.E.N.A.L. score, and preoperative creatinine are predictive of benign histology, but the ability of different variables to predict benign lesions may be influenced by the distribution of benign tumor subtypes, reflecting potential unidentified selection bias.
本研究旨在调查术前影像学检查怀疑为恶性肿瘤的患者接受部分肾切除术(PN)后良性组织学的发生率。此外,还评估了良性病变的术前预测因素和围手术期结局。
使用前瞻性维护的数据库识别一系列因肾肿块接受PN的患者。如果患者存在已知的遗传疾病、切除了一个以上的肾肿块或标准术前影像学检查对肾细胞癌(RCC)不怀疑,则将其排除。评估良性和恶性病理患者之间特征的差异。
共识别出916例在2007年至2015年间接受PN的患者,其中129例(14.1%)最终诊断为良性疾病。最常见的良性病理类型是嗜酸细胞瘤(n = 66,51.2%)、血管平滑肌脂肪瘤(n = 37,28.7%)和复杂性囊肿(n = 10,7.8%)。多因素分析显示,低体重指数(BMI)[0.96(0.92 - 0.99),p = 0.02]、低R.E.N.A.L.评分[0.86(0.76 - 0.96),p = 0.007]和低术前肌酐水平[0.37(0.14 - 0.91),p = 0.04]可预测良性组织学。肿瘤大小在额外建模中是一个显著的预测因素[0.81(0.69 - 0.94),p = 0.008]。良性组织学患者的手术时间明显较短(p < 0.001),估计失血量较少(p < 0.001),并发症发生率(p = 0.93)或输血率(0.24)无差异。
在本研究中,疑似RCC患者接受PN后良性病理的发生率为14.1%。BMI、R.E.N.A.L.评分和术前肌酐可预测良性组织学,但不同变量预测良性病变的能力可能受良性肿瘤亚型分布的影响,反映出潜在的未识别选择偏倚。